Osteoblastoma
When diagnosing osteoblastoma, the preliminary radiologic workup should consist of radiography of the site of the patient's pain. However, computed tomography (CT) is often necessary to support clinical and plain radiographic findings suggestive of osteoblastoma and to better define the margins of the lesion for potential surgery. CT scans are best used for the further characterization of the lesion with regard to the presence of a nidus and matrix mineralization. MRI aids in detection of nonspecific reactive marrow and soft tissue edema, and MRI best defines soft tissue extension, although this finding is not typical of osteoblastoma. Bone scintigraphy (bone scan) demonstrates abnormal radiotracer accumulation at the affected site, substantiating clinical suspicion, but this finding is not specific for osteoblastoma. In many patients, biopsy is necessary for confirmation.
Raymond Damadian
According to a "Wall Street Journal" article, Damadian's initial methods were flawed for practical use, relying on a point-by-point scan of the entire body and using relaxation rates, which turned out to not be an effective indicator of cancerous tissue. However, the same article pointed out, “Nevertheless, his observation of T and T differences in cancerous tissue was a Eureka moment for Paul Lauterbur.” Furthermore, Damadian's seminal paper documented in its Table 2 that T relaxation times were different, beyond experimental uncertainty, across all his samples over different healthy tissues: rectus muscle, liver, stomach, small intestine, kidney, and brain. This showed the way to accurate imaging of the body's soft tissues for the first time; X-ray imaging was severely deficient for soft tissue analysis because the difference in absorption was so small (<4%). 
So when in the court case Fonar v. General Electric, GE's attorneys made the same claim that relaxations times were also prolonged in non-cancerous tissue, so were not a good diagnostic, Fonar's attorneys responded that it was unfair to punish Damadian because his methods detected even "more" features than he had intended. Indeed, even today, 90% of MRI scans on patients produce images that are relaxation dependent, either T- or T-dependent images.
In 1974, he received the first patent in the field of MRI when he patented the concept of NMR for detecting cancer after filing an application in 1972—now there are over 4,500 patents on MRI. As the National Science Foundation notes, “The patent included the idea of using NMR to ‘scan’ the human body to locate cancerous tissue.” However, it did not describe a method for generating pictures from such a scan or precisely how such a scan might be done. But without Damadian's discovery of the profound sensitivity of the relaxation time to different tissue types and malignant tissue, there would be no picture at all.
In the 1950s, Herman Carr reported creating a one-dimensional MR image. Prompted by Damadian's report on the potential medical uses of NMR, Paul Lauterbur expanded on Carr's technique and developed a way to generate the first MRI images, in 2D and 3D, using gradients. Peter Mansfield from the University of Nottingham then developed a mathematical technique that would allow scans to take seconds rather than hours and produce clearer images than Lauterbur had. While Lauterbur and Mansfield focused on animals and human limbs, Damadian built the first full-body MRI machine and produced the first full magnetic resonance imaging ("MRI") scan of the human body, albeit using a “focused field” technique that differs considerably from modern imaging. In recording the history of MRI, Mattson and Simon (1996) credit Damadian with describing the concept of whole-body NMR scanning, as well as discovering the NMR tissue relaxation differences that made this feasible.